NMDA ( DrugBank: NMDA )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	6

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03858270 (ClinicalTrials.gov)	April 1, 2019	2/10/2018	Inhibition of a-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine	Inhibition of a-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine	Parkinson Disease	Drug: Memantine;Other: Placebo	Wayne State University	NULL	Recruiting	45 Years	85 Years	All	50	Phase 3	United States
2	NCT01785628 (ClinicalTrials.gov)	August 2010	24/6/2011	The Impact of Pharmacological and Electric Modulation of NMDAPathway on the Cognitive Flexibility an ...		Parkinson's Disease With Dementia	Dietary Supplement: Sarcosine Capsule;Dietary Supplement: Placebo Capsule	China Medical University Hospital	National Science Council, Taiwan	Completed	N/A	N/A	All	30	N/A	Taiwan
3	NCT00163085 (ClinicalTrials.gov)	May 2005	9/9/2005	The Effects of an NR2B NMDA Antagonist, CP-101,606, in Patients With Parkinson's Disease	A Randomized, Double-Blind, Placebo-Controlled, Crossover Study To Explore The Efficacy And Safety O ...	Parkinson's Disease	Drug: NR2B NMDA Antagonist CP-101,606 (traxoprodil)	Pfizer	NULL	Completed	30 Years	80 Years	Both	12	Phase 2	United States
4	NCT00375778 (ClinicalTrials.gov)	April 2005	12/9/2006	Parkinson's Disease Evaluated by PET and the Effect of Memantine	Parkinson's Disease Evaluated by Positron Emission Tomography and the Effect of the NMDAReceptor Ant ...	Parkinson's Disease	Drug: memantine (drug)	University of Aarhus	Lundbeck Foundation	Completed	50 Years	70 Years	Both	12	N/A	Denmark
5	NCT00001929 (ClinicalTrials.gov)	March 1999	3/11/1999	Treatment of Parkinson's Disease With Eliprodil	NMDA-Receptor Blockade With Eliprodil in Parkinson's Disease	Movement Disorders;Parkinson Disease	Drug: Eliprodil	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	N/A	N/A	Both	20	Phase 2	United States
6	NCT00001365 (ClinicalTrials.gov)	July 1993	3/11/1999	Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous Syst ...	NMDA Receptor Antagonist Treatment of Neurodegenerative Disease	Neurodegenerative Disease;Parkinson's Disease	Drug: dextromethorphan	National Institute of Neurological Disorders and Stroke (NINDS)	NULL	Completed	N/A	N/A	Both	42	Phase 2	United States

First Previous1Next Last